ALK Positive UK TRIANA Group This questionnaire is only for UK or Ireland patients who have been referred to the Triana TRI-611 clinical trial. It is expected that the TRIANA trial of TRI-611 will be open for several years and the Charity wishes to gather the real-world experiences of UK patients. If you have been referred for the trial, whether you have been accepted or not, we would be grateful if you could complete this questionnaire. We will not share any personal information and any information that we publish will be anonymised. You can read our Privacy Notice HERE. Question Title * 1. Name (Required.) Question Title * 2. Email (Required.) Question Title * 3. Telephone Question Title * 4. When were you diagnosed with ALK-positive NSCLC? Year Month Question Title * 5. How many TKIs have you been prescribed? (Required.) 1 2 3 4 5 6 Comment Question Title * 6. Which TKIs have you been prescribed? (Required.) Crizotinib Ceritinib Alectinib Brigatinib Lorlatinib Neledalkib Comment Question Title * 7. Have you received chemotherapy at any time for your lung cancer? (Required.) Yes No Question Title * 8. Have you been referred for the TRIANA trial? (Required.) Yes No Next